Pharmaceuticals North America

North America Exosome Therapeutics Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

North America Exosome Therapeutics Market Industry Trends and Forecast to 2034: Segmented by (Application, Source, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

North America · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $123.4 Mn Placeholder estimate
Estimate 2025 $152.8 Mn 48.9% of the global market
Projected 2034 $1.04 Bn 583.1% Adds $891.0 Mn over 9 forecast years
CAGR 2025–2034 23.8% Faster than 93% of 180 Pharmaceuticals markets here
Key players 5 Companies profiled
  • North America is 48.9% of the global market.
  • Among regions, the largest is North America (this report) at $152.8 Mn.
  • Fastest growing: Africa at 26.6% a year.
  • North America ranks 1st of 6 by size among regions.

Market size projection

North America

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$891.0 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Exosome Therapeutics Market market size by year, North America
YearMarket sizeChange that yearSince 2025
2024 (estimate) $123.4 Mn — —
2025 (base) $152.8 Mn +$29.4 Mn —
2026 (forecast) $189.2 Mn +$36.4 Mn +23.8%
2027 (forecast) $234.2 Mn +$45.0 Mn +53.3%
2028 (forecast) $289.9 Mn +$55.7 Mn +89.7%
2029 (forecast) $358.9 Mn +$69.0 Mn +134.9%
2030 (forecast) $444.4 Mn +$85.4 Mn +190.8%
2031 (forecast) $550.1 Mn +$105.8 Mn +260%
2032 (forecast) $681.1 Mn +$130.9 Mn +345.7%
2033 (forecast) $843.1 Mn +$162.1 Mn +451.8%
2034 (forecast) $1.04 Bn +$200.7 Mn +583.1%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

North America Exosome Therapeutics Market Analysis at a glance
Market size, 2025$152.8 Mn placeholder estimate
Forecast, 2034$1.04 Bn placeholder estimate
Growth (CAGR), 2025–203423.8% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsApplication, source and end user (see all)
Key playersCodiak BioSciences, Evox Therapeutics, Aegle Therapeutics, Capricor Therapeutics, ExoCoBio, Inc (see all)
Active clinical trials32 in North AmericaSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in North America. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The North America Exosome Therapeutics Market Analysis Executive Summary

Exosome therapeutics use tiny vesicles released by cells to carry drugs or healing signals, for cancer, inflammation and regenerative medicine.

Key segments of the exosome Therapeutics market include application (Drug Delivery, Regenerative Medicine and Diagnostics) and source (Stem Cell-Derived, Plant-Derived and Engineered).

Bar chart: North America Exosome Therapeutics market size, 2024–2034, placeholder estimates. $123.4 Mn in 2024, $152.8 Mn in 2025 and $1.04 Bn in 2034, 23.8% CAGR.
North America Exosome Therapeutics market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

North America Exosome Therapeutics Market Dynamics

Market Growth Drivers

Approvals of the first curative gene and cell therapies, strong investment in biotech, better manufacturing and growing evidence in rare and blood diseases are driving the exosome Therapeutics market.

Opportunity

Allogeneic (off-the-shelf) products, in-vivo delivery and use in common diseases open large growth for the exosome Therapeutics market.

Market Restraints

Very high prices, complex manufacturing, limited treatment centres and uncertain long-term safety hold back the exosome Therapeutics market. Payers are still working out how to pay for one-time cures.

Competitive Landscape for Exosome Therapeutics Market in North America

The exosome Therapeutics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Exosome Therapeutics Market in North America

Exosome Therapeutics in North America: rules, payment and research

In the countries we cover here, medicines are approved by Health Canada (Canada)⁠[1] and FDA (US)⁠[2]. How care is paid for in these countries: provincial health insurance (Canada)⁠[3] and Medicare and Medicaid (US)⁠[4]. ClinicalTrials.gov lists 32 studies on Exosome Therapeutics that are recruiting, active or about to start in North America.⁠[5]

[1] Health Canada. Checked 14 Nov 2026.

[2] US Food and Drug Administration. Checked 14 Nov 2026.

[3] Health Canada. Checked 14 Nov 2026.

[4] Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.

[5] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in North America. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for exosome Therapeutics. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in North America.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Exosome Therapeutics right now, from free public sources.

Clinical trials

32 active trials in US and Canada

Recruiting, about to start, or running now. Counted across the 2 countries we report on in North America.

Top trial sponsors (worldwide)

  1. Biocells Medical 3 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Exosome Therapeutics in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Exosome Therapeutics market in North America?
Placeholder estimate: about $152.8 Mn in 2025, rising to about $1.04 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Exosome Therapeutics market in North America growing?
Placeholder estimate: about 23.8% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Exosome Therapeutics market report cover?
The report splits the market by application (Drug Delivery, Regenerative Medicine, Diagnostics, Oncology), source (Stem Cell-Derived, Plant-Derived, Engineered) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Exosome Therapeutics market?
Key players include Codiak BioSciences, Evox Therapeutics, Aegle Therapeutics, Capricor Therapeutics and ExoCoBio, Inc.
What is driving the Exosome Therapeutics market?
Approvals of the first curative gene and cell therapies, strong investment in biotech, better manufacturing and growing evidence in rare and blood diseases are driving the exosome Therapeutics market.
How many clinical trials on Exosome Therapeutics are running in North America?
32 studies are recruiting, active or about to start in North America, counted across the 2 countries we report on there, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in North America. Retrieved 12 Nov 2026.
How much research is published on Exosome Therapeutics?
PubMed lists 29 papers on Exosome Therapeutics added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Pharmaceuticals reports in North America

See all

Related on biologics and biosimilars and genomics

See the topic